US/UK/Canada

Share

About Us

QVance is a quality analytics service provider for advanced therapies. The company’s vision is to be a one-stop analytics service supporting customers throughout development and drug product lifecycle.

Pick a time period -
Tags ( Active)

QVance AB Announces Collaboration with SKAN

QVance AB, Huddinge, Sweden has today announced it has entered into a collaboration with SKAN AG securing a rigorous sterile environment for the performance of quality control analytics for cell and gene therapy product development and release at QVance’s site in Huddinge.SKAN is recognised as a global leader for provision of high-class isolators, cleanroom devices and decontamination processes for aseptic handling of biopharmaceutical substances, such as advanced therapy medicinal products (ATMPs). Through this collaboration SKAN has installed a pure2 isolator in QVance’s cleanroom,

QVance’s co-founder is elected to Vice President Elect for ISCT

QVance AB, Huddinge, Sweden has today announced that its co-founder Dr Lindsay Davies, has been elected by the European membership of the International Society of Cell and Gene Therapy (ISCT) to the role of Vice President (VP) Elect for Europe.Dr Davies, who is the current Secretary for Europe and the inaugural Chair for the ISCT’s European Industry Committee, will commence her role after the Annual Meeting for the society to be held in New Orleans in May 2025. Her position as VP Elect will be for two years before she will ascend to VP for a further two years. Dr Davies commented, “I am

QVance Announces Partnership with Royale International to Drive Innovation in End-to-End Cell and Gene Therapy Cold Chain Distribution and Quality Control

QVance has today announced that it has entered into a partnership with Royale International, a global leader in logistics and supply chain management. This collaboration marks a significant milestone in the development of end-to-end cold chain distribution and quality control analytical services solutions for the cell and gene therapy sector.The partnership combines Royale International's extensive expertise in international shipping and logistics management with QVance's innovative solutions in quality analytical services for advanced therapies. Together, the two companies aim to address

QVance AB Announces Nordic Partnership with bioMérieux

QVance AB, Huddinge, Sweden has today announced it has entered into a partnership with bioMérieux Sweden AB, aimed at enhancing the quality analytics offerings in microbiology and mycoplasma testing for cell and gene therapy product development and releasebioMérieux, a world leader in the field of in vitro diagnostics, pioneer, develop and produce high quality diagnostic solutions to improve public health worldwide. This collaboration will leverage the strengths of both companies to offer innovative solutions and support the advanced therapy community in the Nordics. QVance, in addition to

QVance AB publishes particulates article in collaboration with ISCT

QVance AB, Huddinge, Sweden has today announced its co-founder and CSO at parent company, NextCell Pharma AB, Dr Lindsay Davies, has published an article in the journal Cytotherapy. Dr Davies is a member of the International Society of Cell and Gene Therapy (ISCT) where she is the European Regional Secretary and a member of the Manufacturing Materials Safety and Technology Working Group (MMST).The article, entitled “Particulates in CGT Guidance Survey Results - Cell and Gene Therapy Industry Knowledge Awareness”, is the result of the MMST´s extensive work to globally survey cell and gene

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe